About US
Contact us
-
New transgenic mouse for recognizing cancer drug side effectsResearchers are able to precisely simulate the inhibition of genes with new cancer drugs Only one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product2011/7/20
-
Woodcock: New drug approvals reach 20-year highIs it too soon for the FDA to call 2011 a good year for drug approvals? Maybe not. CDER director Janet Woodcock claims that new chemical and molecular entity approvals have reached a 20-year high, and2011/7/19
-
U.S. FDA approves 2011-2012 influenza vaccine formulationThe U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce an2011/7/19
-
Transcept decreases workforce to reduce expenses following FDA news on Intermezzo NDATranscept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today plans to reduce operating expenses by eliminating approximately 45% of its workforce following notification from the U.S. Food and Drug A2011/7/18
-
SFDA Deputy Commissioner Bian Zhenjia meets Director General of Social Work Department of LOCPG and President of the Hong Kong Federation of Trade UnionsOn July 11, 2011, Bian Zhenjia, Deputy Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Mr. Zhang Tiefu, Director General of Social Work Department of the Liaison O2011/7/14
-
SAS expands Global Certification Program offeringsSAS, the leader in business analytics software and services and the de facto industry standard for clinical data analysis and reporting in the life sciences/pharmaceutical industry, today expanded its2011/7/14
-
New approach for producing human-derived gelatinScientists are reporting development of a new approach for producing large quantities of human-derived gelatin that could become a substitute for some of the 300,000 tons of animal-based gelatin produ2011/7/14
-
BRICS health ministers agree to improve access to low-cost medicinesHealth ministers from Brazil, Russia, India, China, and South Africa in Beijing "on Monday vowed to improve access to low-cost and high-quality medicine - and called on developed nations to shoulder r2011/7/13
-
Gilead Joins Medicines Patent PoolGilead Sciences has signed up to the Medicines Patent Pool to improve access to HIV treatments in developing countries, becoming the first pharmaceutical firm to do so. Founded in 2010, the Medici2011/7/13
-
SFDA makes stage achievements in the special operation against IPR infringement and counterfeitingIn order to ensure drug safety for the public, aiming at the current characteristics of the production and distribution of counterfeit drugs, The State Food and Drug Administration (SFDA) cracks down2011/7/12